Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rastogi

Showing results (101-110 of 198) with videos related to

Pageof 20
Sort By:
FEMS Microbiology Immunology|July 1, 1992
Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusionsN Rastogi, M Bachelet, J P Carvalho de Sousa
Acta Leprologica|January 1, 1989
Comparative intracellular growth of difficult-to-grow and other mycobacteria in a macrophage cell lineN Rastogi, M C Blom-Potar, H L David
Journal of Clinical Microbiology|April 1, 1997
Molecular fingerprinting of Mycobacterium tuberculosis on a Caribbean island with IS6110 and DRr probesC Sola, L Horgen, K S Goh, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineN Rastogi, K S Goh, A Bryskier, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisN Rastogi, K S Goh, A Bryskier, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCGN Rastogi, K S Goh, M Berchel, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|December 1, 1992
Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs?N Rastogi, K S Goh, N Guillou, et al.
Acta Leprologica|October 1, 1984
Macrophage interaction with mycobacteria including M. lepraeA Ryter, C Frehel, N Rastogi, et al.
Infection and Immunity|April 1, 1986
Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium aviumC Frehel, C de Chastellier, T Lang, et al.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie|April 22, 2022
Microsatellite instability in north Indian colorectal cancer patients and its clinicopathological correlationA Yadav, A Kumar, N Rastogi, et al.
Pageof 20

Showing results (101-110 of 198) with videos related to

Sort By:
Pageof 20
FEMS Microbiology Immunology|July 1, 1992
Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusionsN Rastogi, M Bachelet, J P Carvalho de Sousa
Acta Leprologica|January 1, 1989
Comparative intracellular growth of difficult-to-grow and other mycobacteria in a macrophage cell lineN Rastogi, M C Blom-Potar, H L David
Journal of Clinical Microbiology|April 1, 1997
Molecular fingerprinting of Mycobacterium tuberculosis on a Caribbean island with IS6110 and DRr probesC Sola, L Horgen, K S Goh, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineN Rastogi, K S Goh, A Bryskier, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisN Rastogi, K S Goh, A Bryskier, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2000
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCGN Rastogi, K S Goh, M Berchel, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|December 1, 1992
Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs?N Rastogi, K S Goh, N Guillou, et al.
Acta Leprologica|October 1, 1984
Macrophage interaction with mycobacteria including M. lepraeA Ryter, C Frehel, N Rastogi, et al.
Infection and Immunity|April 1, 1986
Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium aviumC Frehel, C de Chastellier, T Lang, et al.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie|April 22, 2022
Microsatellite instability in north Indian colorectal cancer patients and its clinicopathological correlationA Yadav, A Kumar, N Rastogi, et al.
Pageof 20